These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6782651)

  • 21. [Double-blind study of proglumide, zolimidine and carbenoxolone in peptic ulcer and gastroduodenitis].
    Corazza GR; D'Ambro A; Grimoldi D
    Minerva Dietol Gastroenterol; 1979; 25(1):47-58. PubMed ID: 156316
    [No Abstract]   [Full Text] [Related]  

  • 22. Pepsins and the mucus barrier in peptic ulcer disease.
    Allen A; Pearson JP; Blackburn A; Coan RM; Hutton DA; Mall AS
    Scand J Gastroenterol Suppl; 1988; 146():50-7. PubMed ID: 3147508
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of peptic aggression by sucralfate. The view from the ulcer crater.
    Samloff IM
    Scand J Gastroenterol Suppl; 1983; 83():7-11. PubMed ID: 6415806
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of carbenoxolone on gastric prostaglandin E release and cytoprotection in the rat.
    Martin A; Gurrieri G; Sturniolo GC; Naccarato R
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 12():409-10. PubMed ID: 6221623
    [No Abstract]   [Full Text] [Related]  

  • 25. Carbenoxolone and incorporation of (3H) glucosamine into gastric mucosa.
    Meek EM; Rhodes J; Mayberry JF
    Curr Med Res Opin; 1978; 5(8):645-7. PubMed ID: 710177
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structure-reactivity relationships for the inhibition mechanism at the second alkyl-chain-binding site of cholesterol esterase and lipase.
    Lin G; Shieh CT; Ho HC; Chouhwang JY; Lin WY; Lu CP
    Biochemistry; 1999 Aug; 38(31):9971-81. PubMed ID: 10433704
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The inhibition by carbenoxolone sodium of individual human pepsinogens and pepsins.
    Roberts NB; Taylor WH
    Clin Sci; 1973 Feb; 44(2):6P-7P passim. PubMed ID: 4579239
    [No Abstract]   [Full Text] [Related]  

  • 28. Review article: human pepsins - their multiplicity, function and role in reflux disease.
    Roberts NB
    Aliment Pharmacol Ther; 2006 Sep; 24 Suppl 2():2-9. PubMed ID: 16939427
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mucosal cell turnover in the upper gut of the mouse and its modification by carbenoxolone [proceedings].
    Henman FD; Adams SS
    Br J Pharmacol; 1978 Nov; 64(3):426P-427P. PubMed ID: 719277
    [No Abstract]   [Full Text] [Related]  

  • 30. [Controlled clinical study of the effectiveness of a new anti-ulcer drug: thiopropamine].
    Masoero G
    Clin Ter; 1979 Aug; 90(3):261-72. PubMed ID: 399873
    [No Abstract]   [Full Text] [Related]  

  • 31. [Value of biogastrone and duodenal biogastrone in the treatment of peptic ulcer].
    Stadnicki A
    Pol Tyg Lek; 1979 Jun; 34(26):1029-31. PubMed ID: 503921
    [No Abstract]   [Full Text] [Related]  

  • 32. [Do ulcerogenic pepsins exist? Characterization of polymorphism of human pepsins].
    Wnuk W; Jordan M; Loizeau E
    Schweiz Med Wochenschr; 1991 Jun; 121(22):836-8. PubMed ID: 2063163
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of triterpenoids related to carbenoxolone upon human pepsins and pepsinogens and upon bovine trypsin and chymotrypsin.
    Waft LA; Roberts NB; Taylor WH
    Clin Sci Mol Med; 1974 Apr; 46(4):519-26. PubMed ID: 4597977
    [No Abstract]   [Full Text] [Related]  

  • 34. Carbenoxolone and prostaglandin E2 and F2 alpha gastric juice levels in man.
    Minuz P; Cavallini G; Angelini GP; Lechi A; Brocco G; Riela A; Scuro LA; Velo GP
    Pharmacol Res Commun; 1984 Sep; 16(9):875-84. PubMed ID: 6594711
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Importance of defensive factors in the prevention of peptic ulcer recurrence. Role of carbenoxolone sodium.
    Guslandi M
    Acta Gastroenterol Belg; 1983; 46(9-10):411-8. PubMed ID: 6673456
    [No Abstract]   [Full Text] [Related]  

  • 36. Carbenoxolone interactions in man--preliminary report.
    Thornton PC; Papouchado M; Reed PI
    Scand J Gastroenterol Suppl; 1980; 65():35-9. PubMed ID: 6937939
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Collateral effects of anti-ulcer therapy with carbenoxolone. General considerations. A clinical case].
    Frabetti F; Zardi V; Grappa P; Dattola L; Bellodi G
    Clin Ter; 1986 Jun; 117(6):455-62. PubMed ID: 3742966
    [No Abstract]   [Full Text] [Related]  

  • 38. Effects of carbenoxolone sodium on gastric and duodenal mucus synthesis in mice.
    Dai S; Ogle CW; Cho CH
    Pharmacology; 1986; 33(1):58-60. PubMed ID: 2426720
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ostrich pepsinogens I and II: purification, activation and chemical and immunochemical characterization of the enzymes from the proventriculus.
    Pletschke BI; Naudé RJ; Oelofsen W; Muramoto K; Yamauchi F
    Int J Biochem Cell Biol; 1995 Jun; 27(6):613-24. PubMed ID: 7671140
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inactivation of glucocorticoids by 11beta-hydroxysteroid dehydrogenase enzymes increases during the meiotic maturation of porcine oocytes.
    Webb RJ; Sunak N; Wren L; Michael AE
    Reproduction; 2008 Dec; 136(6):725-32. PubMed ID: 18787080
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.